Antibacterial Activity of Amifloxacin (WIN 49, 375), a New Quinolone Agent
- 1 November 1985
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 3 (6) , 469-478
- https://doi.org/10.1016/s0732-8893(85)80003-1
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- In vitro comparison of amifloxacin and six other antibiotics against aminoglycoside-resistant Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1984
- Antimicrobial spectrum of Win 49375Antimicrobial Agents and Chemotherapy, 1984
- Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populationsAntimicrobial Agents and Chemotherapy, 1984
- In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillinAntimicrobial Agents and Chemotherapy, 1984
- Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1984
- Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analoguesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprimAntimicrobial Agents and Chemotherapy, 1983
- In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprimAntimicrobial Agents and Chemotherapy, 1982